2,3,4-Trifluorobenzoic acid | CAS:61079-72-9

We serve 2,3,4-Trifluorobenzoic acid CAS:61079-72-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2,3,4-Trifluorobenzoic acid

Chemical Name:2,3,4-Trifluorobenzoic acid
CAS.NO:61079-72-9
Synonyms:2,3,4-trifluoro benzoic acid;
Molecular Formula:C7H3F3O2
Molecular Weight:176.09300
 
Physical and Chemical Properties:
Density:1.536;
Melting point:140-142oC;
Boiling point:245.3oC;
Flash point:102.1oC;
Index of Refraction:1.482;
 
Specification:
Appearance:White powder
Purity(HPLC):≥99.0%
Moisture:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis
 



Contact us for information like 2,3,4-Trifluorobenzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,3,4-trifluoro benzoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,3,4-trifluoro benzoic acid Use and application,2,3,4-trifluoro benzoic acid technical grade,usp/ep/jp grade.


Related News: Green Valley said it would launch the drug “very soon” in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug.tert-butyl N-(3-aminophenyl)carbamate manufacturer Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.2,4-diphenyl-7,8-dihydro-6H-quinolin-5-one supplier Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylic acid vendor Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.The first case of the 2019 novel coronavirus in Massachusetts has been confirmed in a man returning from Wuhan, China who is in his 20s and lives in Boston. The Massachusetts Department of Public Health (DPH) and the Boston Public Health Commission (BPHC) were notified by the US Centers for Disease Control and Prevention (CDC) of the positive test results late Friday evening. This is the eighth case of infection with 2019 novel coronavirus reported in the United States. The risk to the public from the 2019 novel coronavirus remains low in Massachusetts.